Mbia Inc.
—- Market cap
- $243.35M
- Debt
- +$4.17B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 6% equity / 94% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $243.35M · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2022 ·
Decision snapshot: MBI stock price at discount vs CTXR $4.77 current versus $281.11 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CTXR's multiple
Implied fair value · at MBI's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: MBI FY 2025 (ended Dec 31, 2025) · CTXR FY 2022 (ended Sep 30, 2022). Fiscal years are not aligned.
Trendline
Eight fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 6% equity / 94% debt
Capital structure 161% equity / -61% debt · EV / EBITDA 0.96x
MBI carries the larger enterprise value at $4.41B against -$31.69M; CTXR trades on the lower EV / EBITDA multiple (0.96x vs 64.92x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MBIA INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Citius Pharmaceuticals, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-1.86x
-0.06x
Net debt / EBITDA
Leverage against operating earnings
—
1.45x
Cash and equivalents
Liquid reserves on the balance sheet
—
$41.71M
Total debt
Interest-bearing obligations outstanding
$4.17B
-$6.11M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ASSURED GUARANTY LTD
MBI vs AGO
RADIAN GROUP INC
MBI vs RDN
AXIS CAPITAL HOLDINGS LTD
MBI vs AXS
CNA FINANCIAL CORP
MBI vs CNA
Zomedica Corp.
MBI vs ZOM
Aquestive Therapeutics, Inc.
MBI vs AQST
ACADIA PHARMACEUTICALS INC
MBI vs ACAD
AMGEN INC
MBI vs AMGN
GILEAD SCIENCES, INC.
MBI vs GILD
AbbVie Inc.
MBI vs ABBV
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.